Category: Diseases & Conditions
Diseases & Conditions market research reports by DelveInsight
-
Dental Pain - Pipeline Insight, 2024
Dental Pain - Pipeline Insight, 2024 Dental Pain Overview ""Dental Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Dental Pain market. A detailed picture of the Dental Pain pipeline landscape ... Read More
-
Mouth & Throat pain - Pipeline Insight, 2024
Mouth & Throat pain - Pipeline Insight, 2024 Mouth & Throat pain Overview ""Mouth & Throat pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Mouth & Throat pain market. A detailed picture of th ... Read More
-
Musculoskeletal Pain - Pipeline Insight, 2024
Musculoskeletal Pain - Pipeline Insight, 2024 Musculoskeletal Pain Overview ""Musculoskeletal Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Musculoskeletal Pain market. A detailed picture o ... Read More
-
Myofascial Pain Syndrome - Pipeline Insight, 2024
Myofascial Pain Syndrome - Pipeline Insight, 2024 Myofascial Pain Syndrome Overview ""Myofascial Pain Syndrome Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Myofascial Pain Syndrome market. A de ... Read More
-
Post Operative Pain Management - Pipeline Insight, 2024
Post Operative Pain Management - Pipeline Insight, 2024 Post Operative Pain Management Overview ""Post Operative Pain Management Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Post Operative Pain ... Read More
-
Inflammatory Pain - Pipeline Insight, 2024
Inflammatory Pain - Pipeline Insight, 2024 DelveInsight’s, “Inflammatory Pain - Pipeline Insight, 2024,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Inflammatory Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More
-
Lumbosacral Radicular Pain - Pipeline Insight, 2024
Lumbosacral Radicular Pain - Pipeline Insight, 2024 Lumbosacral Radicular Pain Overview ""Lumbosacral Radicular Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Lumbosacral Radicular Pain mark ... Read More
-
Post Surgical Pain - Pipeline Insight, 2024
Post Surgical Pain - Pipeline Insight, 2024 Post Surgical Pain Overview ""Post Surgical Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Post Surgical Pain market. A detailed picture of the Po ... Read More
-
Complex regional pain syndromes- Pipeline Insight, 2024
Complex regional pain syndromes- Pipeline Insight, 2024 DelveInsight’s, “Complex regional pain syndromes- Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Complex regional pain syndromes pipeline landscape. It covers the pipeline drug profile ... Read More
-
Peripheral Neuropathic Pain - Pipeline Insight, 2024
Peripheral Neuropathic Pain - Pipeline Insight, 2024 DelveInsight’s, “Peripheral Neuropathic Pain - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Peripheral Neuropathic Pain pipeline landscape. It covers the pipeline drug profiles, inclu ... Read More
-
Anti-hypertension - Pipeline Insight, 2024
Anti-hypertension - Pipeline Insight, 2024 Anti-hypertension Overview ""Anti-hypertension Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Anti-hypertension market. A detailed picture of the Anti-h ... Read More
-
Anti-Epileptic Drugs/Epilepsy - Pipeline Insight, 2024
Anti-Epileptic Drugs/Epilepsy - Pipeline Insight, 2024 Anti-Epileptic Drugs/Epilepsy Overview ""Anti-Epileptic Drugs/Epilepsy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Anti-Epileptic Drugs/E ... Read More
-
Anaplastic Thyroid Cancer - Pipeline Insight, 2024
Anaplastic Thyroid Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Thyroid Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Anaplastic Thyroid Cancer pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More
-
Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2024
Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2024 Allergic Bronchopulmonary Aspergillosis Overview ""Allergic Bronchopulmonary Aspergillosis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects acr ... Read More
-
Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024
Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024 DelveInsight’s, “Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024,” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Chronic Hepatitis B Virus Infection pipeline landscape. It covers the pi ... Read More
-
Chronic Myeloid Leukemia - Pipeline Insight, 2024
Chronic Myeloid Leukemia - Pipeline Insight, 2024 DelveInsight’s, “Chronic Myeloid Leukaemia- Pipeline Insight, 2024,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Myeloid Leukaemia pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More
-
Chronic lymphocytic leukemia- Pipeline Insight, 2024
Chronic lymphocytic leukemia- Pipeline Insight, 2024 DelveInsight’s, “Chronic lymphocytic leukemia- Pipeline Insight, 2024” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic lymphocytic leukemia pipeline landscape. It covers the pipeline drug profiles, incl ... Read More
-
Anal Cancer - Market Insight, Epidemiology And Market Forecast - 2034
Anal Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Anal cancer is relatively uncommon, accounting for about 2.7% of all reported gastrointestinal cancers in the United States. Anal cancer is more prevalent among women than men and is most frequently diagnosed betwee ... Read More
-
Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology And Market Forecast - 2034
Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The market size of ALS in 2023, in the 7MM was ALS ~ USD 1,000 million. The current standard of care that involves the prescription of riluzole has been effective in slowing the disease ... Read More
-
Cervical Cancer - Market Insight, Epidemiology And Market Forecast - 2034
Cervical Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The US accounted for the largest market size of cervical cancer, i.e., nearly USD 530 million in 2023. Cervical cancer is most often diagnosed between the ages of 35 and 44. The average age of diagnosis in the U ... Read More
-
Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034
Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034 Key Highlights wAIHA is the most common type of autoimmune hemolytic anemia. People of any age, including children, may develop wAIHA, but it is more common among adults, with a peak incidence between 50 and 70 years. The median ... Read More
-
Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032
Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights The main treatment options for ALL include chemotherapy, targeted therapy, immunotherapy, surgery, radiation therapy, and stem cell transplant. In 2021, the market size of ALL in the 7MM was app ... Read More
-
Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034
Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, in the 7MM the total market size of wAIHA was ~ USD 300 million. wAIHA is the most common type of autoimmune hemolytic anemia, comprising nearly 70–80% of all adult cases and 50% of pediatric ... Read More
-
Parainfluenza Virus Infection Market Insight, Epidemiology And Market Forecast - 2034
Parainfluenza Virus Infection Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Acute Respiratory Distress Syndrome (ARDS) is a critical condition characterized by the rapid onset of respiratory failure due to extensive inflammation in the lungs. This syndrome can arise from var ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated i ... Read More
Research Assistance
